Provided by Tiger Trade Technology Pte. Ltd.

Progyny

25.65
-0.3100-1.19%
Post-market: 25.650.00000.00%19:30 EDT
Volume:1.08M
Turnover:27.58M
Market Cap:1.97B
PE:28.28
High:26.27
Open:26.08
Low:25.24
Close:25.96
52wk High:33.07
52wk Low:16.10
Shares:76.73M
Float Shares:70.79M
Volume Ratio:1.17
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9071
EPS(LYR):0.6500
ROE:16.24%
ROA:10.14%
PB:4.34
PE(LYR):39.46

Loading ...

Company Profile

Company Name:
Progyny
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
846
Office Location:
1359 Broadway,New York,New York,United States
Zip Code:
10018
Fax:
- -
Introduction:
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Directors

Name
Position
David Schlanger
Director and Executive Chairman
Peter Anevski
Chief Executive Officer and Director
Jeff Park
Lead Independent Director
Cheryl Scott
Director
Debra Morris
Director
Elizabeth Bierbower
Director
Kevin Gordon
Director
Lloyd Dean
Director
Norman Payson
Director
Roger Holstein
Director

Shareholders

Name
Position
Peter Anevski
Chief Executive Officer and Director
Melissa Cummings
Chief Operating Officer
Mark Livingston
Chief Financial Officer
Allison Swartz
Executive Vice President and General Counsel and Secretary
David Schlanger
Director and Executive Chairman
Geoffrey Clapp
Chief Product Officer